Screener / SEC EDGAR /CIK 0000851205 /10-K filed Feb 12, 2026, compared with Feb 13, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Technology · Industrial Instruments

Cognex Corp CGNX

Compare with peers Embed
Earnings releases

Latest results release: Nov 4, 2026

8-K item 2.02, exhibit 99

What CGNX's management wrote with each quarter's results: the press release and, when the company files them, its prepared remarks or the call transcript. The call itself is not filed with SEC, so most quarters have the release only.

Adjusted vs GAAP earnings per share

In the company's own words · read from each release, never computed

In its release of Nov 4, 2026, CGNX reported $0.50 per share under GAAP and $0.53 on its own adjusted basis: the adjusted number is +6% above GAAP.

GAAP EPS $0.14, release Apr 30, 2025: Net income per diluted share was $0.14 compared to $0.07 in the first quarter of 2024, an increase of 99%. Adjusted EPS $0.16, release Apr 30, 2025: Adjusted diluted earnings per share were $0.16 compared to $0.11 in the first quarter of 2024, an increase of 41%. +14% 2025-04 GAAP EPS $0.24, release Jul 30, 2025: Net income per diluted share was $0.24 Adjusted EPS $0.25, release Jul 30, 2025: Net income per diluted share was $0.24; Adjusted diluted earnings per share were $0.25, an increase of 12% year over year, fourth consecutive quarter of growth. +4% 2025-07 GAAP EPS $0.10, release Oct 29, 2025: Net income per diluted share was $0.10 Adjusted EPS $0.33, release Oct 29, 2025: Net income per diluted share was $0.10; Adjusted diluted earnings per share were $0.33, an increase of 69% year over year, the fifth consecutive quarter of growth. +230% 2025-10 GAAP EPS $0.19, release Feb 11, 2026: Fourth-quarter net income per diluted share was $0.19 Adjusted EPS $0.27, release Feb 11, 2026: Fourth-quarter net income per diluted share was $0.19; Adjusted diluted earnings per share were $0.27, an increase of 35% year over year, the sixth consecutive quarter of double-digit growth. +42% 2026-02 GAAP EPS $0.31, release May 6, 2026: Net income per diluted share was $0.31 Adjusted EPS $0.34, release May 6, 2026: Net income per diluted share was $0.31; Adjusted diluted earnings per share of $0.34 increased 113% year over year, representing the seventh straight quarter of growth. +10% 2026-05 GAAP EPS $0.43, release Aug 5, 2026: Net income per diluted share was $0.43 Adjusted EPS $0.45, release Aug 5, 2026: generated Adjusted diluted earnings per share of $0.45, up 80% year over year, representing the eighth consecutive quarter of growth. +5% 2026-08 GAAP EPS $0.50, release Nov 4, 2026: Net income per diluted share was $0.50 Adjusted EPS $0.53, release Nov 4, 2026: generated Adjusted diluted earnings per share of $0.53, up 61% year over year, representing the ninth consecutive quarter of growth. +6% 2026-11
GAAP EPSAdjusted EPS, as the company defines itThe figure on top is how far adjusted is from GAAP. Click a bar for the sentence.
The company's words, latest release
Net income per diluted share was $0.50 release
generated Adjusted diluted earnings per share of $0.53, up 61% year over year, representing the ninth consecutive quarter of growth. release

What the company says its adjusted numbers leave out:

The year-on-year increase in adjusted net income was driven by revenue growth excluding Moritex, the contribution from Moritex and leverage on our operating expenses. release Feb 12, 2025

Both numbers are read from the words of each release (usually the highlights), never computed by us; hover a number for its sentence. Quarters where the release gives them only in a table are not shown. The company decides what "adjusted" leaves out; the full reconciliation is in the release.

Read and search

Every release, in full · linked to sec.gov

Press release Nov 4, 2026 · EX-99.1

Cognex Reports Third Quarter 2026

Open on SEC

November 4, 2026 — NATICK, MA — Cognex Corporation (NASDAQ: CGNX), the global technology leader in industrial machine vision, today reported financial results for the third quarter ended October 4, 2026 .

• Achieved record quarterly revenue of $313 million, an increase of 13% year over year, driven by broad-based strength across most major end markets; excluding the Q3 2025 one-time benefit from the commercial partnership with a medical lab automation channel partner (the "Commercial Partnership” or “CP”), revenue grew 19% year over year.

• Operating margin was 32.2% ; delivered an Adjusted EBITDA margin of 35.5% , up 1,060 basis points year over year. Excluding the CP, Adjusted EBITDA margin expanded 1,340 basis points year over year , marking the ninth consecutive quarter of margin expansion .

• Net income per diluted share was $0.50; generated Adjusted diluted earnings per share of $0.53, up 61% year over year, representing the ninth consecutive quarter of growth. Excluding the CP, Adjusted EPS (diluted) increased 89% year over year.

• Increased full-year 2026 guidance; continue to anticipate strong double-digit revenue growth and year-over-year expansion in profitability.

• Announced the entry into a definitive agreement to acquire RealSense, Inc., a leader in depth-sensing cameras and vision technology for robotic perception and physical artificial intelligence (AI). The all-cash transaction is expected to close during the fourth quarter of 2026.

• Announced the launch of the In-Sight ® 1750, a next-generation wafer and panel identification system designed for the Semiconductor industry, one of the most demanding automation markets.

“Our third-quarter results reflect strong execution across the business, with record revenue, broad-based growth across most of our major end markets, and continued progress against our strategic objectives,” said Matt Moschner, President and CEO. “We believe we are strengthening our leadership in AI-powered machine vision through innovation, expanding our long-term growth opportunity through the announced acquisition of RealSense, and continuing to help position Cognex to benefit from what we see as powerful trends in automation, robotics, and artificial intelligence.”

Dennis Fehr, CFO, added, “We believe Q3 was another strong proof point for our profitable growth strategy. Record revenue, significant margin expansion, and Adjusted EBITDA flow-through above 100% demonstrate the progress we have made transforming our operating model. Our strong balance sheet and disciplined capital allocation strategy enabled us to pursue the RealSense acquisition, while retaining flexibility to invest in both organic and inorganic growth opportunities with the potential to create further value for shareholders.” 1 Financial Performance Highlights for the Third Quarter

1 Adjusted EBITDA and Adjusted EPS (Diluted) include non-GAAP adjustments. A reconciliation from GAAP to non-GAAP metrics is provided in this news release. • Revenue was $313 million , compared with $277 million in the second quarter of 2025 , an increase of 13%, driven by broad-based strength across most major end markets. Excluding the one-time benefit from the Commercial Partnership, revenue grew 19% year over year. Foreign currency exchange did not have a meaningful impact on consolidated revenue in the quarter.

• Gross margin was 70.8% compared to 67.6% in the third quarter of 2025 . Adjusted gross margin was 71.3% compared to 68.4% in the third quarter of 2025 , an in crease of 290 basis points. The year-over-year increase was primarily driven by favorable mix, higher volume, and faster-than-expected pricing execution. These benefits more than offset the expected memory cost headwinds in the quarter.

• Operating expenses were $121 million compared to $130 million in the third quarter of 2025 , a decrease of 7% . Adjusted operating expenses were $116 million compared to $125 million in the third quarter of 2025 , a decrease of 7%, primarily reflecting continued cost management activities, somewhat offset by higher sales commissions.

• Operating income was $ 101 million compared to $58 million in the third quarter of 2025 , an increase of 74% . Operating margin was 32.2% compared to 20.9% in the third quarter of 2025 , an increase of 1,130 basis points . Adjusted operating margin was 34.2% compared to 23.2% in the third quarter of 2025 , an increase of 1,100 basis points .

• Adjusted EBITDA was $111 million compared to $69 million in the third quarter of 2025 , an increase of 61% . Adjusted EBITDA margin was 35.5% compared to 24.9% in the third quarter of 2025 , an increase of 1,060 basis points. Excluding the one-time benefit from the Commercial Partnership, Adjusted EBITDA margin increased 1,340 basis points year over year, driven by revenue growth, strong Adjusted Gross Margin and disciplined cost management.

• Net income of $85 million compared to $18 million in the third quarter of 2025 , an increase of 372% . Adjusted net income of $90 million compared to $56 million in the third quarter of 2025 , an increase of 61% .

• Net income per diluted share was $0.50 compared to $0.10 in the third quarter of 2025 , an increase of 400% . Adjusted diluted earnings per share were $0.53 compared to $0.33 in the third quarter of 2025 , an increase of 61%. Excluding the one-time benefit from the Commercial Partnership, Adjusted diluted earnings per share increased 89% year over year. 2 Balance Sheet and Cash Flow Highlights • As of October 4, 2026, Cognex’s financial position remained strong, with $846 million in cash and investments and no debt. • During the third quarter, Cognex generated $106 million of cash from operating activities compared to $87 million in the third quarter of 2025, an increase of 22%. • During the third quarter, Cognex generated Free Cash Flow (FCF) of $104 million compared to $86 million in the third quarter of 2025, an increase of 21%. Third quarter FCF conversion rate was 122% of net income and 116% of Adjusted net income. Trailing twelve-month FCF conversion rate was 118% of net income and 106% of Adjusted net income. • Cognex paid $14 million in dividends to shareholders in the third quarter. Dividend On November 4, 2026, Cognex's Board of Directors declared a quarterly cash dividend of $0.09 per share, representing an increase of $0.005 per share, or approximately 6%, over the $0.085 per share dividend paid in the prior quarter. The dividend is payable on December 3, 2026, to all shareholders of record at the close of business on November 19, 2026. Guidance Cognex issued fourth-quarter guidance and increased full-year 2026 guidance; details are summarized in the tables below. Table 1: Fourth-Quarter 2026 Guidance

* At the midpoint of guidance. 3 1 Cognex has provided the forward-looking non-GAAP measures of adjusted EBITDA margin, and adjusted earnings per share (diluted), but cannot, without unreasonable effort, forecast such items to present or provide a reconciliation to corresponding forecasted GAAP measures. These include special items such as reorganization charges, acquisition and integration charges, and amortization of acquisition-related intangible assets, all of which are subject to limitations in predictability of timing, ultimate outcome and numerous conditions outside of Cognex’s control. Additionally, these items are outside of Cognex’s normal business operations and not used by management to assess Cognex’s operating results. Cognex believes these limitations would result in a range of projected values so broad as to not be meaningful to investors. For these reasons, Cognex believes that the probable significance of such information is low. Information with respect to special items for certain historical periods is included in the section entitled “Reconciliation of Selected Items From GAAP to Non-GAAP”. In Q4 2025, the GAAP operating margin was 14.0% and GAAP earnings per share (diluted) were $0.19, and in full-year 2025, the GAAP operating margin was 16.3% and GAAP earnings per share (diluted) were $0.68.

• Cognex will host a conference call on November 5, 2026, at 8:30 a.m. Eastern Standard Time (EDT). The telephone number is (877) 704-4573 or (201) 389-0911 if outside the United States. • A real-time audio broadcast of the conference call or an archived recording, together with a slide presentation, will be accessible on the Events & Presentations page of the Cognex Investor website: www.cognex.com/investor. 4

Certain statements made in this release, as well as oral statements made by Cognex Corporation ("Cognex", "we", "us", "our", or the "Company") from time to time, constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). We intend such forward- looking statements to be covered by the safe harbor provisions for forward- looking statements contained in the Private Securities Litigation Reform Act of 1995. Readers can identify these forward-looking statements by our use of the words "expects," "anticipates," "estimates," "potential," "believes," "projects," "intends," "plans," "aims," "will," "may," "shall," "could," "should," "opportunity," "goal," "objective," "target," "milestone" and similar words and other statements of a similar sense. These statements are based on our current estimates and expectations as to prospective events and circumstances, which may or may not be in our control and as to which there can be no firm assurances given. These forward-looking statements, which include statements regarding business and market trends, future financial performance, financial targets, milestones and related timing expectations, the closing, timing, integration, and expected results from acquired businesses, including RealSense, Inc. ("RealSense"), the impact of tariffs, customer demand and order rates and timing of related revenue, future product or revenue mix, research and development activities, sales and marketing activities including our salesforce transformation, new product offerings, innovation and product development activities, customer acceptance of our products, commercial partnerships, capital expenditures, cost management activities including expected annualized operating expense reductions, investments, liquidity, dividends and stock repurchases, strategic and growth plans and opportunities, financial and operating models, and estimated tax benefits and expenses, changes in tax legislation, and other tax matters, involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include: (1) the technological obsolescence of current products, the inability to develop new products, and the inability to achieve growth through expanding and adjacent markets; (2) the impact of competitive pressures; (3) the inability to attract and retain skilled employees and effectively plan for succession, while maintaining our unique corporate culture; (4) the failure to properly manage the timely manufacturing and distribution of high-quality products and services; (5) economic, political, and other risks associated with international sales and operations, including the impact of trade disputes, the imposition of tariffs, the economic climate in China, and the wars and conflicts involving Iran, Ukraine, and Israel and those that may arise in the future in the geographies where we conduct business; (6) challenges in closing, integrating, and achieving expected results from acquired businesses, including RealSense, as well as exposure to potential liabilities and increased costs from acquired businesses; (7) uncertainty surrounding our future capital needs; (8) the inability to effectively scale our operations and salesforce to support a significantly expanded and diverse customer base in an increasing number of geographies; (9) information security breaches and other cybersecurity threats, including through the emergence of agentic AI; (10) the failure to comply with laws or regulations relating to data privacy, data protection, artificial intelligence, or other automated technologies; (11) the inability to protect our proprietary technology and data, as well as our intellectual property; (12) the inability to manage direct and indirect disruptions to our supply chain, which could cause delays in obtaining components for our products at reasonable prices, including memory chips; (13) the loss of, or curtailment of purchases by, large customers in the logistics, consumer electronics, or automotive end markets; (14) challenges in accurately forecasting our financial results due to seasonal and cyclical variations in customer purchasing patterns and economic and market volatility; (15) potential impairment charges with respect to our investments or acquired intangible assets; (16) exposure to additional tax liabilities, increases and fluctuations in our effective tax rate, and other tax matters; (17) fluctuations in foreign currency exchange rates and the use of derivative instruments; (18) unfavorable global economic conditions, including, without limitation, increases in interest rates, elevated inflation rates, and recession risks; (19) business disruptions from natural or man-made disasters, public health crises, or other events outside our control; (20) stock price volatility; (21) our involvement in time- consuming and costly litigation or activist shareholder activities; and (22) the failure to effectively transform our operating model, manage our expenses, and achieve expected cost reductions. The foregoing list should not be construed as exhaustive and we encourage readers to refer to the detailed discussion of risk factors included in Part I - Item 1A of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the "Annual Report"), as updated by Part II - Item 1A of our Quarterly Reports on Form 10-Q as filed with the SEC. The Company cautions readers not to place undue reliance upon any such forward- looking statements, which speak only as of the date made. The Company disclaims any obligation to subsequently revise forward-looking statements to reflect the occurrence of anticipated or unanticipated events or circumstances after the date such statements are made. 5

December 31, October 4, 2026 2025 ────────────────────────────────────────────────────────────────────────────── -unaudited ASSETS Current assets: Cash and cash $ 694,695 $ 262,925 equivalents Current 997 74,037 investments Accounts receivable, net of allowance for credit 216,720 146,713 losses of $781 and $728 in 2026 and 2025, respectively Unbilled 12,763 16,980 revenue Inventories 158,453 137,889 Prepaid expenses and 68,206 58,702 other current assets Total current 1,151,834 697,246 assets Non-current 150,292 305,339 investments Property, plant, and 79,720 86,015 equipment, net Operating lease 66,153 72,310 assets Goodwill 386,105 386,279 Intangible 63,295 81,100 assets, net Deferred income 374,517 383,272 taxes Other assets 4,551 4,994 Total assets $ 2,276,467 $ 2,016,555 LIABILITIES AND SHAREHOLDERS’ EQUITY Current liabilities: Accounts $ 74,708 $ 50,203 payable Accrued 88,618 91,397 expenses Accrued income 10,627 9,141 taxes Deferred revenue and 42,450 21,094 customer deposits Operating lease 12,314 11,716 liabilities Total current 228,717 183,551 liabilities Non-current operating lease 58,048 64,870 liabilities Deferred income 243,132 250,512 taxes Reserve for 23,000 24,269 income taxes Other 2,080 1,452 liabilities Total 554,977 524,654 liabilities Shareholders’ equity: Preferred stock, $.01 par value – Authorized: 400 shares in — — 2026 and 2025, respectively; no shares issued and outstanding Common stock, $.002 par value – Authorized: 300,000 shares in 2026 and 2025, respectively; 337 334 issued and outstanding: 168,372 and 166,997 shares in 2026 and 2025, respectively Additional 1,310,477 1,138,708 paid-in capital Retained 467,646 406,355 earnings Accumulated other comprehensive -56,970 -53,496 loss, net of tax Total shareholders’ 1,721,490 1,491,901 equity Total liabilities and $ 2,276,467 $ 2,016,555 shareholders' equity

This press release includes certain non-GAAP financial measures, including adjusted gross profit and margin, adjusted operating expense, adjusted operating income and margin, adjusted EBITDA and margin, adjusted net income, adjusted earnings per share of common stock, diluted, adjusted effective tax rate, and free cash flow and free cash flow conversion rate. Cognex defines its non-GAAP metrics as follows:

• Adjusted gross profit and margin : Gross margin adjusted for amortization of acquisition-related intangible assets, as well as, if applicable, restructuring charges, reorganization charges, acquisition and integration costs and one-time discrete events .

• Adjusted operating expense : Operating expense adjusted for amortization of acquisition-related intangible assets, as well as, if applicable, restructuring charges, reorganization charges, acquisition and integration costs and one-time discrete events .

• Adjusted operating income and margin : Operating income adjusted for amortization of acquisition-related intangible assets, as well as, if applicable, restructuring charges, reorganization charges, acquisition and integration costs and one-time discrete events .

• Adjusted EBITDA and margin : Operating income adjusted for amortization of acquisition-related intangible assets and depreciation, as well as, if applicable, restructuring charges, reorganization charges, acquisition and integration costs and one-time discrete events.

• Adjusted net income: Net income adjusted for amortization of acquisition- related intangible assets, as well as, if applicable, restructuring charges, reorganization charges, acquisition and integration costs, discrete tax items, tax impact on reconciling items and one-time discrete events (such as loss on sale of business) .

• Adjusted earnings per share of common stock, diluted: Adjusted net income divided by diluted weighted average common and common-equivalent shares.

• Adjusted effective tax rate: Effective tax rate adjusted for discrete tax items and the net impact of the other non-GAAP adjustments.

• Free cash flow: Cash provided by operating activities less cash for capital expenditures.

• Free cash flow conversion rate: Free cash flow divided by net income or adjusted net income, as applicable.

Cognex may disclose results on a constant-currency basis as one measure to evaluate its performance and compare results between periods as if the exchange rates had remained constant period-over-period.

Cognex believes these non-GAAP financial measures are helpful because they allow investors to more accurately compare results over multiple periods using the same methodology that management employs in its budgeting process, in its review of operating results, and for forecasting and planning for future periods. Cognex’s definitions may differ from the definitions used by other companies and therefore comparability may be limited. In addition, other companies may not publish these or similar metrics. Furthermore, these measures have certain limitations in that they do not include the impact of certain non-recurring expenses that are reflected in our consolidated statement of operations that are necessary to run our business. Thus, our non-GAAP financial measures should be considered in addition to, not as substitutes for, or in isolation from, measures prepared in accordance with GAAP.

Please see the section “Reconciliation of Selected Items from GAAP to Non-GAAP” below for more detailed information regarding non-GAAP financial measures herein, including the items reflected in our adjusted financial metrics and a description of these adjustments. 8

9 Description of adjustments: In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP measures that incorporate adjustments for the impacts of special items. Adjustments incorporated in the preparation of these non-GAAP measures for the periods presented include the items described below:

• The company incurs expense related to its normal use of property, plant and equipment.

• The Company has incurred charges related to the purchase and integration of acquired businesses. During the periods presented, these costs were primarily related to the ongoing integration of Moritex Corporation, which the company acquired in the fourth quarter of 2023.

• The Company excludes the amortization of acquired intangible assets from non- GAAP expense and income measures. These items are inconsistent in amount and frequency and are significantly impacted by the timing and size of acquisitions, and include the amortization of customer relationships, completed technologies, and trademarks that originated from prior acquisitions. The largest driver of intangible asset amortization was the acquisition of Moritex Corporation.

• The Company has incurred charges related to the reorganization of its employees. During the three-month period ended October 4, 2026, these costs consisted primarily of severance and consulting fees.

• The Company has recognized a pre-tax loss related to the divestiture of its Japan-focused trading business, which includes direct costs associated with the divestiture incurred during the nine-month period ended October 4, 2026. Losses on sale of investments to fund acquisition: • The Company has recognized a pre-tax loss related to the sale of investments, primarily corporate bonds, during the three-month period ended October 4, 2026. The proceeds from these sales, along with existing cash balances, are intended to fund the acquisition of RealSense that is expected to close in the fourth quarter of 2026.

• Items unrelated to current period ordinary income or (loss) that generally relate to changes in tax laws, adjustments to prior period’s actual liability determined upon filing tax returns, adjustments to previously recorded reserves for uncertain tax positions, establishments and adjustments of valuation allowances, stock based compensation, and adjustments to deferred tax positions.

• We estimate the tax effect of items identified in the reconciliation by applying the statutory tax rate to the pre-tax amount. 10

For over 40 years, Cognex has been making advanced machine vision easy, paving the way for manufacturing and distribution companies to become faster, smarter, and more efficient through automation. Innovative technology in our vision sensors and systems solves critical manufacturing and distribution challenges, providing unparalleled performance across a diverse set of end markets, including logistics, consumer electronics, automotive, packaging, and semiconductor.

Cognex makes these tools more capable and easier to deploy thanks to a longstanding focus on AI, helping factories and warehouses improve quality and maximize efficiency without needing highly technical expertise. We are headquartered near Boston, USA, with locations in over 30 countries and more than 30,000 customers worldwide. Learn more at cognex.com.

Full text with the tables
                                                                                
  Exhibit 99.1                                                                  
                                                                                
                                                                                
  Cognex Reports Third Quarter 2026                                             
                                                                                
                                                                                
  Results                                                                       
                                                                                
November 4, 2026 — NATICK, MA — Cognex Corporation (NASDAQ: CGNX), the global
technology leader in industrial machine vision, today reported financial results
for the third quarter ended October 4, 2026 .
                                                                                
  Third-Quarter Financial and Operating Highlights                              
                                                                                
• Achieved record quarterly revenue of $313 million, an increase of 13% year
over year, driven by broad-based strength across most major end markets;
excluding the Q3 2025 one-time benefit from the commercial partnership with a
medical lab automation channel partner (the "Commercial Partnership” or “CP”),
revenue grew 19% year over year.

• Operating margin was 32.2% ; delivered an Adjusted EBITDA margin of 35.5% , up
1,060 basis points year over year. Excluding the CP, Adjusted EBITDA margin
expanded 1,340 basis points year over year , marking the ninth consecutive
quarter of margin expansion .

• Net income per diluted share was $0.50; generated Adjusted diluted earnings
per share of $0.53, up 61% year over year, representing the ninth consecutive
quarter of growth. Excluding the CP, Adjusted EPS (diluted) increased 89% year
over year.

• Increased full-year 2026 guidance; continue to anticipate strong double-digit
revenue growth and year-over-year expansion in profitability.

• Announced the entry into a definitive agreement to acquire RealSense, Inc., a
leader in depth-sensing cameras and vision technology for robotic perception and
physical artificial intelligence (AI). The all-cash transaction is expected to
close during the fourth quarter of 2026.

• Announced the launch of the In-Sight ® 1750, a next-generation wafer and panel
identification system designed for the Semiconductor industry, one of the most
demanding automation markets.

• Cognex to host 2027 Investor Day in June at its Natick, MA headquarters.

“Our third-quarter results reflect strong execution across the business, with
record revenue, broad-based growth across most of our major end markets, and
continued progress against our strategic objectives,” said Matt Moschner,
President and CEO. “We believe we are strengthening our leadership in AI-powered
machine vision through innovation, expanding our long-term growth opportunity
through the announced acquisition of RealSense, and continuing to help position
Cognex to benefit from what we see as powerful trends in automation, robotics,
and artificial intelligence.”

Dennis Fehr, CFO, added, “We believe Q3 was another strong proof point for our
profitable growth strategy. Record revenue, significant margin expansion, and
Adjusted EBITDA flow-through above 100% demonstrate the progress we have made
transforming our operating model. Our strong balance sheet and disciplined
capital allocation strategy enabled us to pursue the RealSense acquisition,
while retaining flexibility to invest in both organic and inorganic growth
opportunities with the potential to create further value for shareholders.”
                                       1                                        
Financial Performance Highlights for the Third Quarter

(Dollars in millions, except per share amounts)
                                                                                
              Three-mon…    September                                           
                   ended     28, 2025     September    Y/Y          Y/Y         
                 October           as    28, 2025ex    Changeas     Changeex    
                04, 2026     Reported            CP    Reported     CP          
 ────────────────────────────────────────────────────────────────────────────── 
  Revenue           $313         $277          $264    +13%         +19%        
  Operati…          $101          $58           $47    +74%         +115%       
  Income                                                                        
  % of             32.2%        20.9%         17.9%    +1,130       +1,430 bps  
  Revenue                                              bps                      
  Adjusted          $111          $69           $58    61%          +91%        
  EBITDA1                                                                       
  % of             35.5%        24.9%         22.1%    +1,060       +1,340 bps  
  Revenue                                              bps                      
  Net                                                                           
  Income                                                                        
  per              $0.50        $0.10         $0.06    +400%        +733%       
  Diluted                                                                       
  Share                                                                         
  Adjusted                                                                      
  EPS              $0.53        $0.33         $0.28    +61%         +89%        
  (Dilute…                                                                      
                                                                                
1 Adjusted EBITDA and Adjusted EPS (Diluted) include non-GAAP adjustments. A
reconciliation from GAAP to non-GAAP metrics is provided in this news release.
• Revenue was $313 million , compared with $277 million in the second quarter of
2025 , an increase of 13%, driven by broad-based strength across most major end
markets. Excluding the one-time benefit from the Commercial Partnership, revenue
grew 19% year over year. Foreign currency exchange did not have a meaningful
impact on consolidated revenue in the quarter.

• Gross margin was 70.8% compared to 67.6% in the third quarter of 2025 .
Adjusted gross margin was 71.3% compared to 68.4% in the third quarter of 2025 ,
an in crease of 290 basis points. The year-over-year increase was primarily
driven by favorable mix, higher volume, and faster-than-expected pricing
execution. These benefits more than offset the expected memory cost headwinds in
the quarter.

• Operating expenses were $121 million compared to $130 million in the third
quarter of 2025 , a decrease of 7% . Adjusted operating expenses were $116
million compared to $125 million in the third quarter of 2025 , a decrease of
7%, primarily reflecting continued cost management activities, somewhat offset
by higher sales commissions.

• Operating income was $ 101 million compared to $58 million in the third
quarter of 2025 , an increase of 74% . Operating margin was 32.2% compared to
20.9% in the third quarter of 2025 , an increase of 1,130 basis points .
Adjusted operating margin was 34.2% compared to 23.2% in the third quarter of
2025 , an increase of 1,100 basis points .

• Adjusted EBITDA was $111 million compared to $69 million in the third quarter
of 2025 , an increase of 61% . Adjusted EBITDA margin was 35.5% compared to
24.9% in the third quarter of 2025 , an increase of 1,060 basis points.
Excluding the one-time benefit from the Commercial Partnership, Adjusted EBITDA
margin increased 1,340 basis points year over year, driven by revenue growth,
strong Adjusted Gross Margin and disciplined cost management.

• Net income of $85 million compared to $18 million in the third quarter of 2025
, an increase of 372% . Adjusted net income of $90 million compared to $56
million in the third quarter of 2025 , an increase of 61% .

• Net income per diluted share was $0.50 compared to $0.10 in the third quarter
of 2025 , an increase of 400% . Adjusted diluted earnings per share were $0.53
compared to $0.33 in the third quarter of 2025 , an increase of 61%. Excluding
the one-time benefit from the Commercial Partnership, Adjusted diluted earnings
per share increased 89% year over year.
                                       2                                        
Balance Sheet and Cash Flow Highlights • As of October 4, 2026, Cognex’s
financial position remained strong, with $846 million in cash and investments
and no debt. • During the third quarter, Cognex generated $106 million of cash
from operating activities compared to $87 million in the third quarter of 2025,
an increase of 22%. • During the third quarter, Cognex generated Free Cash Flow
(FCF) of $104 million compared to $86 million in the third quarter of 2025, an
increase of 21%. Third quarter FCF conversion rate was 122% of net income and
116% of Adjusted net income. Trailing twelve-month FCF conversion rate was 118%
of net income and 106% of Adjusted net income. • Cognex paid $14 million in
dividends to shareholders in the third quarter. Dividend On November 4, 2026,
Cognex's Board of Directors declared a quarterly cash dividend of $0.09 per
share, representing an increase of $0.005 per share, or approximately 6%, over
the $0.085 per share dividend paid in the prior quarter. The dividend is payable
on December 3, 2026, to all shareholders of record at the close of business on
November 19, 2026. Guidance Cognex issued fourth-quarter guidance and increased
full-year 2026 guidance; details are summarized in the tables below. Table 1:
Fourth-Quarter 2026 Guidance
                                                                                
  (Dollars in millions,                                                         
  except per share          Q4 2026 Guidance    Q4 2025 Results    Y/Y Change*  
  amounts)                                                                      
  Revenue                   $270 - $290                    $252    +11%         
  Adj. EBITDA Margin1       29% - 32%                     22.7%    +780 bps     
  Adj. EPS (diluted)1       $0.37 - $0.41                 $0.27    +44%         
                                                                                
Table 2: Full-Year 2026 Guidance
                                                                                
  (Dolla…                                                                       
  in                                                                            
  millio…    New 2026    Prior          2025       2025    Y/Y         Y/Y      
  except     Guidance    2026        Results    Results    Change*     Change*  
  per                    Guidan…                  ex CP                ex CP    
  share                                                                         
  amount…                                                                       
             $1,143 -    $1,130                                                 
  Revenue    $1,163      -              $994       $982    +16%        +17%     
                         $1,150                                                 
  Adj.       31% -       29% -                             +1,000      +1,080   
  EBITDA     32%         31%           21.5%      20.7%    bps         bps      
  Margin1                                                                       
  Adj.       $1.68 -     $1.64 -                                                
  EPS        $1.72       $1.68         $1.02      $0.97    +67%        +75%     
  (dilut…                                                                       
                                                                                
* At the midpoint of guidance. 3
1 Cognex has provided the forward-looking non-GAAP measures of adjusted EBITDA
margin, and adjusted earnings per share (diluted), but cannot, without
unreasonable effort, forecast such items to present or provide a reconciliation
to corresponding forecasted GAAP measures. These include special items such as
reorganization charges, acquisition and integration charges, and amortization of
acquisition-related intangible assets, all of which are subject to limitations
in predictability of timing, ultimate outcome and numerous conditions outside of
Cognex’s control. Additionally, these items are outside of Cognex’s normal
business operations and not used by management to assess Cognex’s operating
results. Cognex believes these limitations would result in a range of projected
values so broad as to not be meaningful to investors. For these reasons, Cognex
believes that the probable significance of such information is low. Information
with respect to special items for certain historical periods is included in the
section entitled “Reconciliation of Selected Items From GAAP to Non-GAAP”. In Q4
2025, the GAAP operating margin was 14.0% and GAAP earnings per share (diluted)
were $0.19, and in full-year 2025, the GAAP operating margin was 16.3% and GAAP
earnings per share (diluted) were $0.68.
                                                                                
  Analyst Conference Call and Simultaneous Webcast                              
                                                                                
• Cognex will host a conference call on November 5, 2026, at 8:30 a.m. Eastern
Standard Time (EDT). The telephone number is (877) 704-4573 or (201) 389-0911 if
outside the United States.
• A real-time audio broadcast of the conference call or an archived recording,
together with a slide presentation, will be accessible on the Events &
Presentations page of the Cognex Investor website: www.cognex.com/investor.
                                       4                                        
                                                                                
  Forward-Looking Statements                                                    
                                                                                
Certain statements made in this release, as well as oral statements made by
Cognex Corporation ("Cognex", "we", "us", "our", or the "Company") from time to
time, constitute forward-looking statements within the meaning of Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"). We intend such forward-
looking statements to be covered by the safe harbor provisions for forward-
looking statements contained in the Private Securities Litigation Reform Act of
1995. Readers can identify these forward-looking statements by our use of the
words "expects," "anticipates," "estimates," "potential," "believes,"
"projects," "intends," "plans," "aims," "will," "may," "shall," "could,"
"should," "opportunity," "goal," "objective," "target," "milestone" and similar
words and other statements of a similar sense. These statements are based on our
current estimates and expectations as to prospective events and circumstances,
which may or may not be in our control and as to which there can be no firm
assurances given. These forward-looking statements, which include statements
regarding business and market trends, future financial performance, financial
targets, milestones and related timing expectations, the closing, timing,
integration, and expected results from acquired businesses, including RealSense,
Inc. ("RealSense"), the impact of tariffs, customer demand and order rates and
timing of related revenue, future product or revenue mix, research and
development activities, sales and marketing activities including our salesforce
transformation, new product offerings, innovation and product development
activities, customer acceptance of our products, commercial partnerships,
capital expenditures, cost management activities including expected annualized
operating expense reductions, investments, liquidity, dividends and stock
repurchases, strategic and growth plans and opportunities, financial and
operating models, and estimated tax benefits and expenses, changes in tax
legislation, and other tax matters, involve known and unknown risks and
uncertainties that could cause actual results to differ materially from those
projected. Such risks and uncertainties include: (1) the technological
obsolescence of current products, the inability to develop new products, and the
inability to achieve growth through expanding and adjacent markets; (2) the
impact of competitive pressures; (3) the inability to attract and retain skilled
employees and effectively plan for succession, while maintaining our unique
corporate culture; (4) the failure to properly manage the timely manufacturing
and distribution of high-quality products and services; (5) economic, political,
and other risks associated with international sales and operations, including
the impact of trade disputes, the imposition of tariffs, the economic climate in
China, and the wars and conflicts involving Iran, Ukraine, and Israel and those
that may arise in the future in the geographies where we conduct business; (6)
challenges in closing, integrating, and achieving expected results from acquired
businesses, including RealSense, as well as exposure to potential liabilities
and increased costs from acquired businesses; (7) uncertainty surrounding our
future capital needs; (8) the inability to effectively scale our operations and
salesforce to support a significantly expanded and diverse customer base in an
increasing number of geographies; (9) information security breaches and other
cybersecurity threats, including through the emergence of agentic AI; (10) the
failure to comply with laws or regulations relating to data privacy, data
protection, artificial intelligence, or other automated technologies; (11) the
inability to protect our proprietary technology and data, as well as our
intellectual property; (12) the inability to manage direct and indirect
disruptions to our supply chain, which could cause delays in obtaining
components for our products at reasonable prices, including memory chips; (13)
the loss of, or curtailment of purchases by, large customers in the logistics,
consumer electronics, or automotive end markets; (14) challenges in accurately
forecasting our financial results due to seasonal and cyclical variations in
customer purchasing patterns and economic and market volatility; (15) potential
impairment charges with respect to our investments or acquired intangible
assets; (16) exposure to additional tax liabilities, increases and fluctuations
in our effective tax rate, and other tax matters; (17) fluctuations in foreign
currency exchange rates and the use of derivative instruments; (18) unfavorable
global economic conditions, including, without limitation, increases in interest
rates, elevated inflation rates, and recession risks; (19) business disruptions
from natural or man-made disasters, public health crises, or other events
outside our control; (20) stock price volatility; (21) our involvement in time-
consuming and costly litigation or activist shareholder activities; and (22) the
failure to effectively transform our operating model, manage our expenses, and
achieve expected cost reductions. The foregoing list should not be construed as
exhaustive and we encourage readers to refer to the detailed discussion of risk
factors included in Part I - Item 1A of the Company's Annual Report on Form 10-K
for the fiscal year ended December 31, 2025 (the "Annual Report"), as updated by
Part II - Item 1A of our Quarterly Reports on Form 10-Q as filed with the SEC.
The Company cautions readers not to place undue reliance upon any such forward-
looking statements, which speak only as of the date made. The Company disclaims
any obligation to subsequently revise forward-looking statements to reflect the
occurrence of anticipated or unanticipated events or circumstances after the
date such statements are made.
                                       5                                        
                                                                                
                               COGNEX CORPORATION                               
                                                                                
                                                                                
                          CONSOLIDATED BALANCE SHEETS                           
                                                                                
                    (in thousands, except per share amounts)                    
                                                                                
                                                   December 31,                 
                     October 4, 2026               2025                         
 ────────────────────────────────────────────────────────────────────────────── 
                     -unaudited                                                 
  ASSETS                                                                        
  Current assets:                                                               
  Cash and cash      $                  694,695    $                   262,925  
  equivalents                                                                   
  Current                                   997                         74,037  
  investments                                                                   
  Accounts                                                                      
  receivable, net                                                               
  of allowance                                                                  
  for credit                            216,720                        146,713  
  losses of $781                                                                
  and $728 in                                                                   
  2026 and 2025,                                                                
  respectively                                                                  
  Unbilled                               12,763                         16,980  
  revenue                                                                       
  Inventories                           158,453                        137,889  
  Prepaid                                                                       
  expenses and                           68,206                         58,702  
  other current                                                                 
  assets                                                                        
  Total current                       1,151,834                        697,246  
  assets                                                                        
  Non-current                           150,292                        305,339  
  investments                                                                   
  Property,                                                                     
  plant, and                             79,720                         86,015  
  equipment, net                                                                
  Operating lease                        66,153                         72,310  
  assets                                                                        
  Goodwill                              386,105                        386,279  
  Intangible                             63,295                         81,100  
  assets, net                                                                   
  Deferred income                       374,517                        383,272  
  taxes                                                                         
  Other assets                            4,551                          4,994  
  Total assets       $                2,276,467    $                 2,016,555  
  LIABILITIES AND                                                               
  SHAREHOLDERS’                                                                 
  EQUITY                                                                        
  Current                                                                       
  liabilities:                                                                  
  Accounts           $                   74,708    $                    50,203  
  payable                                                                       
  Accrued                                88,618                         91,397  
  expenses                                                                      
  Accrued income                         10,627                          9,141  
  taxes                                                                         
  Deferred                                                                      
  revenue and                            42,450                         21,094  
  customer                                                                      
  deposits                                                                      
  Operating lease                        12,314                         11,716  
  liabilities                                                                   
  Total current                         228,717                        183,551  
  liabilities                                                                   
  Non-current                                                                   
  operating lease                        58,048                         64,870  
  liabilities                                                                   
  Deferred income                       243,132                        250,512  
  taxes                                                                         
  Reserve for                            23,000                         24,269  
  income taxes                                                                  
  Other                                   2,080                          1,452  
  liabilities                                                                   
  Total                                 554,977                        524,654  
  liabilities                                                                   
  Shareholders’                                                                 
  equity:                                                                       
  Preferred                                                                     
  stock, $.01 par                                                               
  value –                                                                       
  Authorized:                                                                   
  400 shares in                               —                              —  
  2026 and 2025,                                                                
  respectively;                                                                 
  no shares                                                                     
  issued and                                                                    
  outstanding                                                                   
  Common stock,                                                                 
  $.002 par value                                                               
  –                                                                             
  Authorized:                                                                   
  300,000 shares                                                                
  in 2026 and                                                                   
  2025,                                                                         
  respectively;                             337                            334  
  issued and                                                                    
  outstanding:                                                                  
  168,372 and                                                                   
  166,997 shares                                                                
  in 2026 and                                                                   
  2025,                                                                         
  respectively                                                                  
  Additional                          1,310,477                      1,138,708  
  paid-in capital                                                               
  Retained                              467,646                        406,355  
  earnings                                                                      
  Accumulated                                                                   
  other                                                                         
  comprehensive                         -56,970                        -53,496  
  loss,                                                                         
  net of tax                                                                    
  Total                                                                         
  shareholders’                       1,721,490                      1,491,901  
  equity                                                                        
  Total                                                                         
  liabilities and    $                2,276,467    $                 2,016,555  
  shareholders'                                                                 
  equity                                                                        
                                                                                
                                       6                                        
                                                                                
                               COGNEX CORPORATION                               
                                                                                
                                                                                
                      CONSOLIDATED STATEMENT OF OPERATIONS                      
                                                                                
                                  (Unaudited)                                   
                                                                                
                    (In thousands, except per share amounts)                    
                                                                                
                  Octob…          Sept…               Octo…          Septe…     
           Thre…      4,            28,       Nine-…     4,             28,     
           Ended    2026           2025       Ended    2026            2025     
 ────────────────────────────────────────────────────────────────────────────── 
  Reve…    $      313,3…       $  276,…       $       873,…       $  742,0…     
  Cost                                                                          
  of              91,644          89,6…               254,…          242,5…     
  reve…                                                                         
  Gross           221,7…          187,…               618,…          499,4…     
  prof…                                                                         
  Perc…                                                                         
  of                70.8  %        67.6  %             70.8  %         67.3  %  
  reve…                                                                         
  Rese…                                                                         
  deve…                                                                         
  and             33,897          35,0…               103,…          102,9…     
  engi…                                                                         
  expe…                                                                         
  Perc…                                                                         
  of                10.8  %        12.7  %             11.8  %         13.9  %  
  reve…                                                                         
  Sell…                                                                         
  gene…                                                                         
  and             87,024          94,4…               268,…          269,2…     
  admi…                                                                         
  expe…                                                                         
  Perc…                                                                         
  of                27.8  %        34.1  %             30.8  %         36.3  %  
  reve…                                                                         
  Oper…           100,8…          57,7…               246,…          127,2…     
  inco…                                                                         
  Perc…                                                                         
  of                32.2  %        20.9  %             28.2  %         17.2  %  
  reve…                                                                         
  Fore…                                                                         
  curr…             -744            840               -2,9…          -3,116     
  gain                                                                          
  (los…                                                                         
  Inve…            3,358          4,197               13,2…          12,227     
  inco…                                                                         
  Other                                                                         
  inco…             -146             61               -2,1…           2,322     
  (exp…                                                                         
  Inco…                                                                         
  befo…                                                                         
  inco…           103,2…          62,8…               254,…          138,7…     
  tax                                                                           
  expe…                                                                         
  Inco…                                                                         
  tax             18,470          45,1…               45,0…          56,945     
  expe…                                                                         
  Net      $      84,820       $  17,6…       $       209,…       $  81,778     
  inco…                                                                         
  Perc…                                                                         
  of                27.1  %         6.4  %             24.0  %         11.0  %  
  reve…                                                                         
  Net                                                                           
  inco…                                                                         
  per                                                                           
  weig…                                                                         
  comm…                                                                         
  and                                                                           
  comm…                                                                         
  shar…                                                                         
  Basic    $        0.50       $   0.11       $        1.25       $    0.49     
  Dilu…    $        0.50       $   0.10       $        1.23       $    0.48     
  Weig…                                                                         
  comm…                                                                         
  and                                                                           
  comm…                                                                         
  shar…                                                                         
  outs…                                                                         
  Basic           168,3…          167,…               167,…          168,3…     
  Dilu…           171,0…          169,…               169,…          169,5…     
  Cash                                                                          
  divi…                                                                         
  per      $       0.085       $  0.080       $       0.255       $   0.240     
  comm…                                                                         
  share                                                                         
  (1)A…                                                                         
  incl…                                                                         
  stoc…                                                                         
  comp…                                                                         
  expe…                                                                         
  as                                                                            
  foll…                                                                         
                                                                                
  Cost                                                                          
  of       $         592       $    489       $       2,109       $   1,694     
  reve…                                                                         
  Rese…                                                                         
  deve…            3,491          3,794               11,9…          11,933     
  and                                                                           
  engi…                                                                         
  Sell…                                                                         
  gene…            7,063          8,133               20,2…          21,022     
  and                                                                           
  admi…                                                                         
  Total                                                                         
  stoc…    $      11,146       $  12,4…       $       34,2…       $  34,649     
  comp…                                                                         
  expe…                                                                         
                                                                                
                                       7                                        
                                                                                
  Non-GAAP Financial Measures                                                   
                                                                                
This press release includes certain non-GAAP financial measures, including
adjusted gross profit and margin, adjusted operating expense, adjusted operating
income and margin, adjusted EBITDA and margin, adjusted net income, adjusted
earnings per share of common stock, diluted, adjusted effective tax rate, and
free cash flow and free cash flow conversion rate. Cognex defines its non-GAAP
metrics as follows:

• Adjusted gross profit and margin : Gross margin adjusted for amortization of
acquisition-related intangible assets, as well as, if applicable, restructuring
charges, reorganization charges, acquisition and integration costs and one-time
discrete events .

• Adjusted operating expense : Operating expense adjusted for amortization of
acquisition-related intangible assets, as well as, if applicable, restructuring
charges, reorganization charges, acquisition and integration costs and one-time
discrete events .

• Adjusted operating income and margin : Operating income adjusted for
amortization of acquisition-related intangible assets, as well as, if
applicable, restructuring charges, reorganization charges, acquisition and
integration costs and one-time discrete events .

• Adjusted EBITDA and margin : Operating income adjusted for amortization of
acquisition-related intangible assets and depreciation, as well as, if
applicable, restructuring charges, reorganization charges, acquisition and
integration costs and one-time discrete events.

• Adjusted net income: Net income adjusted for amortization of acquisition-
related intangible assets, as well as, if applicable, restructuring charges,
reorganization charges, acquisition and integration costs, discrete tax items,
tax impact on reconciling items and one-time discrete events (such as loss on
sale of business) .

• Adjusted earnings per share of common stock, diluted: Adjusted net income
divided by diluted weighted average common and common-equivalent shares.

• Adjusted effective tax rate: Effective tax rate adjusted for discrete tax
items and the net impact of the other non-GAAP adjustments.

• Free cash flow: Cash provided by operating activities less cash for capital
expenditures.

• Free cash flow conversion rate: Free cash flow divided by net income or
adjusted net income, as applicable.

Cognex may disclose results on a constant-currency basis as one measure to
evaluate its performance and compare results between periods as if the exchange
rates had remained constant period-over-period.

Cognex believes these non-GAAP financial measures are helpful because they allow
investors to more accurately compare results over multiple periods using the
same methodology that management employs in its budgeting process, in its review
of operating results, and for forecasting and planning for future periods.
Cognex’s definitions may differ from the definitions used by other companies and
therefore comparability may be limited. In addition, other companies may not
publish these or similar metrics. Furthermore, these measures have certain
limitations in that they do not include the impact of certain non-recurring
expenses that are reflected in our consolidated statement of operations that are
necessary to run our business. Thus, our non-GAAP financial measures should be
considered in addition to, not as substitutes for, or in isolation from,
measures prepared in accordance with GAAP.

Please see the section “Reconciliation of Selected Items from GAAP to Non-GAAP”
below for more detailed information regarding non-GAAP financial measures
herein, including the items reflected in our adjusted financial metrics and a
description of these adjustments.
                                       8                                        
                                                                                
                               COGNEX CORPORATION                               
                                                                                
                                                                                
             RECONCILIATION OF SELECTED ITEMS FROM GAAP TO NON-GAAP             
                                                                                
                                                                                
                 Dollars in thousands, except per share amounts                 
                                                                                
                                  (Unaudited)                                   
                                                                                
                  Octob…              Septe…          Octo…          Septe…     
           Thre…      4,       Nine…     28,             4,             28,     
           Ended    2026       Ended    2025           2026            2025     
 ────────────────────────────────────────────────────────────────────────────── 
  Gross                                                                         
  prof…    $      221,7…       $      187,2…       $  618,…       $  499,4…     
  (GAA…                                                                         
  Acqu…                                                                         
  and                219                 213            653             666     
  inte…                                                                         
  costs                                                                         
  Amor…                                                                         
  of                                                                            
  acqu…            1,317               1,379          3,977           4,099     
  inta…                                                                         
  asse…                                                                         
  Reor…              274                 400          1,569             486     
  char…                                                                         
  Adju…                                                                         
  gross    $      223,5…       $      189,2…       $  624,…       $  504,7…     
  prof…                                                                         
  GAAP                                                                          
  gross             70.8  %             67.6  %        70.8  %         67.3  %  
  marg…                                                                         
  Adju…                                                                         
  gross             71.3  %             68.4  %        71.5  %         68.0  %  
  marg…                                                                         
  Oper…                                                                         
  expe…    $      120,9…       $      129,5…       $  372,…       $  372,1…     
  (GAA…                                                                         
  Acqu…                                                                         
  and             -2,553                -180          -2,5…            -977     
  inte…                                                                         
  costs                                                                         
  Amor…                                                                         
  of                                                                            
  acqu…             -954              -1,260          -3,1…          -3,846     
  inta…                                                                         
  asse…                                                                         
  Reor…             -951              -2,966          -6,0…          -4,588     
  char…                                                                         
  Adju…                                                                         
  oper…    $      116,4…       $      125,1…       $  360,…       $  362,7…     
  expe…                                                                         
  Oper…                                                                         
  inco…    $      100,8…       $      57,765       $  246,…       $  127,2…     
  (GAA…                                                                         
  Acqu…                                                                         
  and              2,772                 393          3,236           1,643     
  inte…                                                                         
  costs                                                                         
  Amor…                                                                         
  of                                                                            
  acqu…            2,271               2,639          7,098           7,945     
  inta…                                                                         
  asse…                                                                         
  Reor…            1,225               3,366          7,610           5,074     
  char…                                                                         
  Adju…                                                                         
  oper…    $      107,0…       $      64,163       $  264,…       $  141,9…     
  inco…                                                                         
  GAAP                                                                          
  oper…             32.2  %             20.9  %        28.2  %         17.2  %  
  marg…                                                                         
  Adju…                                                                         
  oper…             34.2  %             23.2  %        30.3  %         19.1  %  
  marg…                                                                         
  Depr…                                                                         
  (adj…                                                                         
  for                                                                           
  amou…                                                                         
  incl…            4,309               4,666          13,1…          14,844     
  in                                                                            
  Acqu…                                                                         
  and                                                                           
  inte…                                                                         
  cost…                                                                         
  Adju…    $      111,3…       $      68,829       $  277,…       $  156,7…     
  EBIT…                                                                         
  Adju…                                                                         
  EBIT…             35.5  %             24.9  %        31.8  %         21.1  %  
  marg…                                                                         
  Net                                                                           
  inco…    $      84,820       $      17,664       $  209,…       $  81,778     
  (GAA…                                                                         
  Acqu…                                                                         
  and              2,772                 393          3,236           1,643     
  inte…                                                                         
  costs                                                                         
  Amor…                                                                         
  of                                                                            
  acqu…            2,271               2,639          7,098           7,945     
  inta…                                                                         
  asse…                                                                         
  Reor…            1,225               3,366          7,610           5,074     
  char…                                                                         
  Loss                                                                          
  on                                                                            
  sale                 —                   —          1,539               —     
  of                                                                            
  busi…                                                                         
  Loss…                                                                         
  on                                                                            
  sale                                                                          
  of               2,407                   —          2,407               —     
  inve…                                                                         
  to                                                                            
  fund                                                                          
  acqu…                                                                         
  Disc…                                                                         
  tax             -1,454              33,650          -2,1…          33,132     
  (ben…                                                                         
  expe…                                                                         
  Tax                                                                           
  impa…                                                                         
  of              -2,242              -1,615          -5,9…          -3,871     
  reco…                                                                         
  items                                                                         
  Adju…                                                                         
  net      $      89,799       $      56,097       $  223,…       $  125,7…     
  inco…                                                                         
  Earn…                                                                         
  per                                                                           
  share                                                                         
  of       $        0.50       $        0.10       $   1.23       $    0.48     
  comm…                                                                         
  stoc…                                                                         
  dilu…                                                                         
  (GAA…                                                                         
  Acqu…                                                                         
  and               0.02                0.00           0.02            0.01     
  inte…                                                                         
  costs                                                                         
  Amor…                                                                         
  of                                                                            
  acqu…             0.01                0.02           0.04            0.05     
  inta…                                                                         
  asse…                                                                         
  Reor…             0.01                0.02           0.04            0.03     
  char…                                                                         
  Loss                                                                          
  on                                                                            
  sale                 —                   —           0.01               —     
  of                                                                            
  busi…                                                                         
  Loss…                                                                         
  on                                                                            
  sale                                                                          
  of                0.01                   —           0.01               —     
  inve…                                                                         
  to                                                                            
  fund                                                                          
  acqu…                                                                         
  Disc…                                                                         
  tax              -0.01                0.20          -0.01            0.20     
  (ben…                                                                         
  expe…                                                                         
  Tax                                                                           
  impa…                                                                         
  of               -0.01               -0.01          -0.04           -0.02     
  reco…                                                                         
  items                                                                         
  Adju…                                                                         
  earn…                                                                         
  per                                                                           
  share    $        0.53       $        0.33       $   1.31       $    0.74     
  of                                                                            
  comm…                                                                         
  stoc…                                                                         
  dilu…                                                                         
  Effe…                                                                         
  tax               17.9  %             71.9  %        17.7  %         41.0  %  
  rate                                                                          
  (GAA…                                                                         
  Disc…                                                                         
  tax                1.4  %            -53.5  %         0.9  %        -23.9  %  
  bene…                                                                         
  (exp…                                                                         
  Net                                                                           
  impa…                                                                         
  of                 0.5  %              0.6  %         0.7  %          0.9  %  
  other                                                                         
  reco…                                                                         
  items                                                                         
  Adju…                                                                         
  effe…             19.8  %             19.0  %        19.3  %         18.0  %  
  tax                                                                           
  rate                                                                          
  Cash                                                                          
  prov…                                                                         
  by       $      106,4…       $      87,485       $  220,…       $  170,6…     
  oper…                                                                         
  acti…                                                                         
  (GAA…                                                                         
  Capi…           -2,639              -1,452          -6,9…          -6,147     
  expe…                                                                         
  Free                                                                          
  cash     $      103,7…       $      86,033       $  213,…       $  164,4…     
  flow                                                                          
                                                                                
                                       9                                        
Description of adjustments:
In addition to reporting financial results in accordance with U.S. GAAP, the
Company also provides various non-GAAP measures that incorporate adjustments for
the impacts of special items. Adjustments incorporated in the preparation of
these non-GAAP measures for the periods presented include the items described
below:

Depreciation:

• The company incurs expense related to its normal use of property, plant and
equipment.

Acquisition and integration costs:

• The Company has incurred charges related to the purchase and integration of
acquired businesses. During the periods presented, these costs were primarily
related to the ongoing integration of Moritex Corporation, which the company
acquired in the fourth quarter of 2023.

Amortization of acquisition-related intangible assets:

• The Company excludes the amortization of acquired intangible assets from non-
GAAP expense and income measures. These items are inconsistent in amount and
frequency and are significantly impacted by the timing and size of acquisitions,
and include the amortization of customer relationships, completed technologies,
and trademarks that originated from prior acquisitions. The largest driver of
intangible asset amortization was the acquisition of Moritex Corporation.

Reorganization charges:

• The Company has incurred charges related to the reorganization of its
employees. During the three-month period ended October 4, 2026, these costs
consisted primarily of severance and consulting fees.

Loss on sale of business:

• The Company has recognized a pre-tax loss related to the divestiture of its
Japan-focused trading business, which includes direct costs associated with the
divestiture incurred during the nine-month period ended October 4, 2026.
Losses on sale of investments to fund acquisition:
• The Company has recognized a pre-tax loss related to the sale of investments,
primarily corporate bonds, during the three-month period ended October 4, 2026.
The proceeds from these sales, along with existing cash balances, are intended
to fund the acquisition of RealSense that is expected to close in the fourth
quarter of 2026.

Discrete tax (benefit) expense and tax impact of reconciling items:

• Items unrelated to current period ordinary income or (loss) that generally
relate to changes in tax laws, adjustments to prior period’s actual liability
determined upon filing tax returns, adjustments to previously recorded reserves
for uncertain tax positions, establishments and adjustments of valuation
allowances, stock based compensation, and adjustments to deferred tax positions.

• We estimate the tax effect of items identified in the reconciliation by
applying the statutory tax rate to the pre-tax amount.
                                       10                                       
                                                                                
  About Cognex Corporation                                                      
                                                                                
For over 40 years, Cognex has been making advanced machine vision easy, paving
the way for manufacturing and distribution companies to become faster, smarter,
and more efficient through automation. Innovative technology in our vision
sensors and systems solves critical manufacturing and distribution challenges,
providing unparalleled performance across a diverse set of end markets,
including logistics, consumer electronics, automotive, packaging, and
semiconductor.

Cognex makes these tools more capable and easier to deploy thanks to a
longstanding focus on AI, helping factories and warehouses improve quality and
maximize efficiency without needing highly technical expertise. We are
headquartered near Boston, USA, with locations in over 30 countries and more
than 30,000 customers worldwide. Learn more at cognex.com.

Investor Relations Contact:

Greer Aviv

Head of Investor Relations
Cognex Corporation

[email protected]
                                       10                                       

Sources

The 8-K item 2.02 filings (SEC EDGAR) and their EX-99 exhibits: the results release and, when filed, prepared remarks or the call transcript.

Also

Said vs did: the targets in these releases against what was then reported. Filings: every filing.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CGNX/export.csv") into a cell.

Next:Presentations
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.